Editorial: Heparan sulfate-binding proteins in health and disease

Lauren A Gandy; Fuming Zhang; Ding Xu; Lars C Pedersen; Kay Grobe; Chunyu Wang

doi:10.3389/fmolb.2024.1386623

Editorial: Heparan sulfate-binding proteins in health and disease

Front Mol Biosci. 2024 Mar 20:11:1386623. doi: 10.3389/fmolb.2024.1386623. eCollection 2024.

Authors

Lauren A Gandy^{1

2}, Fuming Zhang¹, Ding Xu³, Lars C Pedersen⁴, Kay Grobe⁵, Chunyu Wang^{1

6

7}

Affiliations

¹ Shirley Ann Jackson, Ph.D. Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY, United States.
² Glycobiology, Cell Growth and Tissue Repair Research Unit (Gly-CRRET), Université Paris-est Créteil, Créteil, France.
³ Department of Oral Biology, School of Dental Medicine, University of Buffalo, The State University of New York, Buffalo, NY, United States.
⁴ Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, NC, United States.
⁵ Institute of Physiological Chemistry and Pathobiochemistry, University of Münster, Münster, Germany.
⁶ Department of Biology, Troy, NY, United States.
⁷ Department of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute, Troy, NY, United States.

No abstract available

Keywords: fucoidan (FPS); glycosaminoglycan (GAG); hedgehog autoprocessing; heparan sulfate (HS); heparin; heparin-binding proteins; sepsis; tauopathies.

Publication types

Editorial

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.